CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
about
eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-free DNAs in Blood.Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.TRAIL-R1 as a novel surface marker for circulating giant cell tumor of bone.The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis.Circulating tumor cells in clinical research and monitoring patients with colorectal cancer.
P2860
CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@en
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@nl
type
label
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@en
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@nl
prefLabel
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@en
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
CD133+CD54+CD44+ circulating t ...... tients with colorectal cancer.
@en
P2093
Chuanwen Fan
Jiankun Hu
Qiaorong Huang
Wentong Meng
Xianming Mo
Yongyang Yu
P2860
P304
77389-77403
P356
10.18632/ONCOTARGET.12675
P407
P577
2016-10-15T00:00:00Z